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Aims: Following intrauterine fetal death (IUFD), the placental
fetal vessels undergo regressive changes. These changes
are virtually indistinguishable from lesions that are the
result of fetal vascular thrombosis (FVT). This study inves-
tigated the relation between these lesions and maternal
thrombophilia.
Methods: Placenta slides of 65 IUFDs with known maternal
thrombophilia test results (compound MTHFR C677T and
A1298C heterozygosity, n¼10; MTHFR 677TT homozy-
gosity, n¼3; protein S deficiency, n¼0; factor V Leiden
mutation, n¼2; prothrombin gene mutation G20210A,
n¼1; lupus anticoagulant, n¼2; antiphospholipid syn-
drome, n¼1; MTHFR C677T heterozygosity, n¼5;
MTHFR A1298C heterozygosity, n¼4; and MTHFR
1298CC homozygosity, n¼2) and of 30 livebirths with
positive maternal thrombophilia test results (n¼5, 2, 0, 9,
2, 0, 2, 7, 2 and 1, respectively, for those thrombophilias)
were microscopically examined for septation, fetal vessel
thrombosis, intimal fibrin cushions, avascular villi, haemo-
rrhagic endovasculitis and fibromuscular sclerosis.
Results: Thirty of the 65 IUFDs had a positive maternal
thrombophilia test; 22 of these 30 had FVT lesions. Thirty
two of the 35 IUFDs with a negative maternal thrombophilia
test had FVT lesions. Septation, defined asmultiple lumens or
‘recanalisation’ in a placental vessel, was the lesion seen
most often in IUFD (n¼41) whether by itself (n¼13) or in
combination with other FVT lesions. Five of the 30 livebirths
had FVT lesions but septation was not seen in any of the
placentas from the 30 livebirths. FVT lesions did not have a
significant relation with maternal thrombophilia.
Conclusions: The finding of fetal vascular thrombosis lesions
in stillbirths does not imply thrombophilia as the cause of the
fetal death. Factors other than thrombophilia may play a role
in the cause of FVT lesions.
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INTRODUCTION
Placental fetal vessels undergo regressive changes following
intrauterine fetal death (IUFD). Due to cessation of the fetal
circulation, there is progressive sclerosis of the blood vessels in
the fetal stem villi with narrowing of their lumina (fibromus-
cular sclerosis) followed by septation and obliteration. There
is hypovascularity followed by stromal fibrosis of terminal
villi, which later become avascular.1–4 These changes are
virtually indistinguishable from lesions that are the result offetal vascular thrombosis, although changes tend to be more
generalised post-mortem.3,5
Stem villous vascular septation presents a diagnostic
difficulty. It has been proposed that the presence of multiple
channels of recanalisation within an organising thrombus
implies that the thrombus occurred when the fetus was alive
and that abnormal coagulation could be a potential aetiological
factor for the thrombus formation and IUFD.6 In pregnancies
with adverse fetal outcomes, such as neonatal seizures and
growth restriction, septation of fetal vessels can be seen in
association with thrombophilia.6,7 Septation of fetal vessels
can be localised and patchy soon after fetal death8 and thus
it becomes unclear whether the cause of the fetal death is due
to fetal thrombotic tendency or the septation of fetal vessels
is merely a post-mortem regressive change. It is clinically
relevant to distinguish between the two as the former warrants
thrombophilia testing and presents a potential modifiable
treatment option. The aim of this study was to investigate
the relation between maternal thrombophilia and placental stem
villous vascular septation and other fetal obstructive vascular
lesions.MATERIAL AND METHODS
Intrauterine fetal death group
All cases of singleton IUFD of 24 or more weeks gestational age delivered in
South Australian public hospitals from January 2001 to December 2006 were
studied if the mothers had been tested for thrombophilia according to the
recommendations of the Perinatal Mortality Subcommittee of the South Aus-
tralian Department of Health; autopsies and placental examination of these
stillbirths were performed in the Women’s and Children’s Hospital,
North Adelaide.
Thrombophilia test results of the mother were subdivided into clinically
significant thrombophilia (MTþ) (protein S deficiency, factor V Leiden
G1691A, prothrombin G20210A gene mutation, lupus anticoagulant, and anti-
phospholipid syndrome), clinically less significant thrombophilia (MT–) [com-
pound methyltetrahydrofolate reductase (MTHFR) C677T and A1298C
heterozygosity, MTHFR 677TT homozygosity, MTHFR C677T or A1298C
heterozygosity, and 1298CC homozygosity] or normal (MTN). Clinically
significant thrombophilias are more likely to cause occlusive vascular disease
than clinically less significant thrombophilias.9
Information about gestational age, maternal age, placental weight, fetal birth
weight, previous stillbirths, gestational complications (pre-eclampsia, gesta-
tional hypertension, placental abruption, gestational diabetes, umbilical cord
complications, chorioamnionitis), fetal complications (growth restriction, fetal
asphyxia, fetal infection) and maternal history (smoking, obesity and medication
use) was collected for each IUFD from the mother’s case notes.
Livebirth group
Thirty random placentas from livebirths with positive thrombophilia test results
were selected from 2004–2006; these women had been tested because of. Unauthorized reproduction of this article is prohibited.
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Fig. 1 Septation of two placental vessels showing multiple lumina which are
separated by fibrin deposition containing erythrocytes.
Fig. 3 Subendothelial intimal fibrin cushion in a placental fetal vessel
(arrowed).
PLACENTAL FETAL VASCULAR THROMBOSIS LESIONS AND MATERNAL THROMBOPHILIA 25previous adverse obstetric history. Information about maternal age, gestational
age, gestational disease, maternal disease and placental weight was collected
from the case notes.
Histology and definition of lesions
The placental slides of all cases were re-examined without knowledge of the
results of the thrombophilia testing. All the placental slides were evaluated for
the presence of septation and other putative features of fetal obstructive vascular
lesions: fetal vessel thrombus, intimal fibrin cushions, avascular villi, haemor-
rhagic endovasculitis, and fibromuscular sclerosis.5 Slides consisted of one
enface and one or more parenchymal full thickness sections per case (mean 5
slides, range 2–11 slides).
Septation is defined as the presence of multiple lumina in fetal stem vessels,
due to fibroblast ingrowth into the vessels, also called ‘recanalisation’ or ‘partial
re-organisation’. There are irregular spaces in the vessels which contain
degenerated blood (Fig. 1). A fetal vessel thrombus is defined as the presence
of an organised occluding or partly occluding thrombus adhering to the
endothelium of the fetal vessel (Fig. 2). Intimal fibrin cushions are seen as
fibrin or fibrinoid depositions (subendothelial or intramuscular), which are
generally located within the wall of a chorionic or large stem villous artery
(Fig. 3). Avascular villi are defined as more than 15 villi in a section showing a
total lack of villous vessels and a hyalinised fibrotic stroma (Fig. 4). Haemor-
rhagic endovasculitis (HEV) is defined by vessel injury, haemorrhage into the
villous stroma, endothelial and medial hyperplasia, karyorrhexis, mural extra-
vasation of erythrocytes, fragmentation of erythrocytes, and occasional haemo-
siderin deposition in the villous stroma (Fig. 5). Fibromuscular sclerosis is
defined as marked thickening of the intimal and medial layers of the stem vessels
with luminal obliteration (Fig. 6). While the other five lesions were often solitaryright © Royal College of Pathologists of Australasia
Fig. 2 Adherent thrombus in a placental fetal vessel.or localised lesions, septation could be multiple and, accordingly, an attempt was
made to estimate the extent and severity of septation. The extent of septation was
defined as focal (scored as 1), intermediate (scored as 2) or diffuse (scored as 3)
if there were fewer than 5, 5–10, or more than 10 septated vessels per slide,
respectively; severity was graded by averaging the sum of the extent scores of all
the slides per case and defined as mild, moderate or severe with scores of 1, 2, or
3, respectively.
Statistical analysis
Comparisons between lesions in the fetal vessels and maternal thrombophilia
were performed using Fisher’s exact test or chi-square test. p values calculated
by Fisher’s test were two-tailed. A p value <0.05 was considered statistically
significant.RESULTS
There were 65 IUFDs that fulfilled the study criteria. The mean
gestational age of the 65 IUFDs was 33 w (range 24–41 w) and
of the 30 livebirths was 38 w (range 36–41 w). The mean
maternal age for the IUFD group was 29 y (range 18–43 y)
and of the livebirth group 33 y (range 19–46 y).
In the IUFD group, 16 women had experienced a previous
IUFD, three women had pre-eclampsia, and 20 delivered a
stillbirth with intrauterine growth restriction. Umbilical cord
abnormalities were present in seven cases (hypercoiled cord,
n¼ 3; true knot, n¼ 1; reduced cord coiling, n¼ 1; excessively
long cord, n¼ 2). Placental abruption was diagnosed in two. Unauthorized reproduction of this article is prohibited.
Fig. 4 Tract of avascular villi with bland hyalinised fibrotic stroma and a lack
of capillaries (right) contrasting with vascular villi (left).
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Fig. 6 Fibromuscular sclerosis with thickening of the intimal and medial layers
of the vessel wall and complete luminal obstruction.
Fig. 5 Haemorrhagic endovasculitis with karyorrhexis, diapedesis of erythro-
cytes and mural disruption.
26 BEEKSMA et al. Pathology (2012), 44(1), Januarycases. In the livebirth group, a previous IUFD was reported in
17 cases; one case had pre-eclampsia and three livebirths were
growth restricted.
The frequencies of the examined placental lesions and
the relationship to thrombophilia test results are shown in
Tables 1 and 2 for the IUFDs and livebirths, respectively.
In the IUFD group, 11 (16.9%) cases did not have any lesion
and of this group, eight cases had a positive maternal
thrombophilia test result. In the livebirth group, which
had been selected randomly on the basis of a positive
maternal thrombophilia test, 25 cases (83.3%) did not have
any lesion. Septation was the most frequently seen lesion
in the 65 IUFD cases, found as a single lesion in 13 cases
(20%) and in combination with other lesions in 28 otherright © Royal College of Pathologists of Australasia
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41 (63%) 13 (20%) 13 (20%) 13 (20%) 10
IUFD, intrauterine fetal death; MTþ, protein S deficiency, factor V Leiden G1691A, p
syndrome; MT, compound MTHFR C677T and A1298C heterozygosity, MTHFR 6
1298CC homozygosity; MTHFR, methyltetrahydrofolate reductase; MTN, normal.cases but it was not seen in any of the placentas of the
30 livebirths.
Six of the 30 IUFD cases with a positive maternal thrombo-
philia test result (MTþ, MT–) were clinically significant
(MTþ), of which five had one or more of the examined
thrombotic placental lesions (Table 1). The types of maternal
thrombophilia abnormalities are listed in Table 3. There was no
significant correlation between any lesion and maternal throm-
bophilia, whether less clinically significant types were included
or not. Any combination of two lesions within a placenta was
not correlated with maternal thrombophilia. Similarly, the
presence of any three, or four or five lesions within a placenta
did not correlate with maternal thrombophilia. Extent or sever-








2 0 1 1
2 0 1 1
2 2 0 0 2
1 0 0 1
0 0 1
1 0 1 0
3 0 0 3
0 1 0
1 0 1 0
2 0 0 2
2 0 0 2
2 2 0 1 1
6 0 3 3
1 1 1




1 1 0 0 1
5 0 1 4
1 7 3
(15%) 26 (40%) 6 24 35
rothrombin G20210A gene mutation, lupus anticoagulant, and antiphospholipid
77TT homozygosity, MTHFR C677T or A1298C heterozygosity, and MTHFR
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Table 2 Relation of placental lesions and maternal thrombophilia in 30 livebirth cases
Septation Fetal vessel thrombosis Intimal fibrin cushion Avascular villi Haemorrhagic endovasculitis Fibromuscular sclerosis MTþ MT
1 1 0




0 (0.0%) 2 (6.7%) 2 (6.7%) 2 (6.7%) 0 (0.0%) 0 (0.0%) 19 11
MTþ, protein S deficiency, factor V Leiden G1691A, prothrombin G20210A gene mutation, lupus anticoagulant, and antiphospholipid syndrome; MT–, compound
MTHFR C677T and A1298C heterozygosity, MTHFR 677TT homozygosity, MTHFR C677T or A1298C heterozygosity, and MTHFR 1298CC homozygosity.
PLACENTAL FETAL VASCULAR THROMBOSIS LESIONS AND MATERNAL THROMBOPHILIA 27DISCUSSION
Although the placental lesions that we evaluated would be
expected to be manifestations of a fetal thrombotic tendency
and have been described under the term fetal thrombotic
vasculopathy, that term has been used differently by various
investigators. These include placentas with ‘multiple (>3) foci
of avascular villi’,10 ‘obliterated vessels’,11 ‘thrombosis of
stem villous arteries with downstream avascular villi’,12 ‘pre-
sence of avascular villi (at least one focus of five or more villi),
thrombosis in a vessel of the umbilical cord, chorionic plate or
stem villus, haemorrhagic endovasculitis, or intramural depo-
sition of fibrin in a vessel of the umbilical cord, chorionic
plate or stem villus;’13 ‘any one or more of extensive avascular
villi, haemorrhagic endovasculitis, obliterated stem arteries
or occlusive thrombi,’14 ‘15 or more avascular terminal villi
per section,’5 ‘one or more of segmental areas of avascular villi,
occlusive and non-occlusive fetal thrombi, and mural fibrin
deposition or calcification within fetal vascular walls.’15
The omission of septation of fetal vessels from the definition
is puzzling. This may be due to the overwhelming presence of
the lesion in stillbirths,6,16,17 particularly after 48 hours of post-
mortem retention.8 The presence of multiple lumina within the
vessel would normally indicate recanalisation of a previously
thrombosed vessel;6,16 thus, it is not surprising that septation of
the vascular lumen of fetal vessels has been observed also in
placentas of liveborns,3,6,7,11,16 albeit infrequently, as we con-
firmed among our liveborn group. Therefore, it was importantright © Royal College of Pathologists of Australasia
Table 3 Maternal thrombophilia test results of IUFD cases with and without








Protein S deficiency 0 0 0
Factor V Leiden mutation 0 2 9
Prothrombin gene mutation 1 0 2
Antiphospholipid syndrome 1 0 0
Lupus anticoagulant 1 1 2
Clinically significant (MT–)
Compound MTHFR heterozygote 5 5 5
Homozygous MTHFR 677TT 3 0 2
Heterozygous MTHFR C677T 2 3 7
Heterozygous MTHFR A1298C 3 1 2
Homozygous MTHFR 1298CC 1 1 1
Total 17 13 30
IUFD, intrauterine fetal death; MTHFR, methyltetrahydrofolate reductase.that we evaluated this lesion also for any possible correlation
with maternal thrombophilia.
Our study has not shown any correlation between maternal
thrombophilia and lesions in the placenta that have been
described under the umbrella of fetal thrombotic vasculopathy.
This is consistent with most studies generally reporting an
absence of a relationship between maternal and/or fetal throm-
bophilia and placental lesions.18–21 In many of these studies,
however, the specific lesion of septation of fetal vessels was not
examined.18 For example, Many et al. did not examine any
possible association with septation of fetal vessels although
they found more infarcts and fibrinoid necrosis of maternal
vessels but not more avascular villi in placentas of women with
thrombophilia.10 Maternal thrombophilia was found to be
associated with maternal floor infarction, massive perivillous
fibrin deposition or fetal vasculopathy; in this study, 9 of 11
placentas with fetal thrombotic vasculopathy had one or more
maternal thrombophilias.12 While septation was not evaluated,
maternal factor V Leiden mutation was not associated with fetal
thrombotic vasculopathy but fetal factor V Leiden mutation
was.22
Given that we were evaluating vascular lesions in the fetal
side of the placental circulation, a more obvious hypothesis
would have been to assess fetal thrombophilia status in relation
to these lesions. However, our study was predicated on two
practical considerations. Firstly, although possible from the
liveborns, we could not test for some fetal thrombophilias such
as protein S deficiency or protein C activity from stillbirths.
Secondly, and more pertinently, we wanted to know whether
the finding of any specific placental lesion should warrant
testing for maternal thrombophilia to inform us of the recur-
rence risk for a subsequent pregnancy. Our finding of an
absence of any relationship between those putative histological
markers of fetal vascular thrombosis and maternal thrombo-
philia, extending previous studies which have not examined
septation,18 would suggest not, whether the outcome was a
stillbirth or a liveborn infant. It has been suggested that
thrombophilia is one of the predisposing factors and umbilical
cord lesions may be the second ‘trigger’ for placental mani-
festations23 but we did not find such an association in our cases
of stillbirths.
The role of maternal thrombophilia in stillbirths is unclear;
no increase in incidence of fetal loss and inherited thrombo-
philia has been found.9 While it is probable that further
inherited thrombophilia mutations will be described, our find-
ing would support that there is insufficient evidence at present
to support routine thrombophilia testing after stillbirths.19 For
the diagnostic anatomical pathologist, the finding of septation
in placentas from liveborns is rare and if the lack of a
relationship between septation and maternal thrombophilia in. Unauthorized reproduction of this article is prohibited.
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28 BEEKSMA et al. Pathology (2012), 44(1), Januarystillbirths is extrapolated, then thrombophilia testing is also
not recommended.
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